Publication | Open Access

Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients

Cell TherapyMedicineImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentPiggybac Transposon SystemRadiation OncologyOncologyCell BiologyEgfr-specific Car-t CellsLung Cancer